Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Gordon

Showing results (321-330 of 327) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 327 results.
The Journal of Biological Chemistry|August 26, 2000
Mammalian GFRalpha -4, a divergent member of the GFRalpha family of coreceptors for glial cell line-derived neurotrophic factor family ligands, is a receptor for the neurotrophic factor persephinS Masure, M Cik, E Hoefnagel, et al.
The Journal of Pediatrics|April 1, 1985
Changing concepts: liver replacement for hereditary tyrosinemia and hepatomaT E Starzl, B J Zitelli, B W Shaw, et al.
European Journal of Biochemistry|December 3, 1999
Enovin, a member of the glial cell-line-derived neurotrophic factor (GDNF) family with growth promoting activity on neuronal cells. Existence and tissue-specific expression of different splice variantsS Masure, H Geerts, M Cik, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2006
Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trialJ A Kobashigawa, J M Tobis, R M Mentzer, et al.
Hospital Record Study : a Joint Study by CPHA and IMS America Ltd|May 14, 2011
WHICH LIVER-DESEASE PATIENTS NEED A TRANSPLANT?: Organ replacement has come into its own as a treatment for end-stage liver disease. A team of experts from two leading transplant centers reviews current indications, survival rates, and methods of evaluating candidates for operationLeonard Makowka, Linda Sher, Delawir Kahn, et al.
European Journal of Biochemistry|June 15, 1996
Cloning and expression of cystolic phospholipase A2 (cPLA2) and a naturally occurring variant. Phosphorylation of Ser505 of recombinant cPLA2 by p42 mitogen-activated protein kinase results in an increase in specific activityR D Gordon, I A Leighton, D G Campbell, et al.
Transplantation|July 27, 1997
Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study GroupL S Sher, C A Cosenza, J Michel, et al.
Pageof 33

Showing results (321-330 of 327) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 327 results.
The Journal of Biological Chemistry|August 26, 2000
Mammalian GFRalpha -4, a divergent member of the GFRalpha family of coreceptors for glial cell line-derived neurotrophic factor family ligands, is a receptor for the neurotrophic factor persephinS Masure, M Cik, E Hoefnagel, et al.
The Journal of Pediatrics|April 1, 1985
Changing concepts: liver replacement for hereditary tyrosinemia and hepatomaT E Starzl, B J Zitelli, B W Shaw, et al.
European Journal of Biochemistry|December 3, 1999
Enovin, a member of the glial cell-line-derived neurotrophic factor (GDNF) family with growth promoting activity on neuronal cells. Existence and tissue-specific expression of different splice variantsS Masure, H Geerts, M Cik, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2006
Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trialJ A Kobashigawa, J M Tobis, R M Mentzer, et al.
Hospital Record Study : a Joint Study by CPHA and IMS America Ltd|May 14, 2011
WHICH LIVER-DESEASE PATIENTS NEED A TRANSPLANT?: Organ replacement has come into its own as a treatment for end-stage liver disease. A team of experts from two leading transplant centers reviews current indications, survival rates, and methods of evaluating candidates for operationLeonard Makowka, Linda Sher, Delawir Kahn, et al.
European Journal of Biochemistry|June 15, 1996
Cloning and expression of cystolic phospholipase A2 (cPLA2) and a naturally occurring variant. Phosphorylation of Ser505 of recombinant cPLA2 by p42 mitogen-activated protein kinase results in an increase in specific activityR D Gordon, I A Leighton, D G Campbell, et al.
Transplantation|July 27, 1997
Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study GroupL S Sher, C A Cosenza, J Michel, et al.
Pageof 33